z-logo
open-access-imgOpen Access
Clear cell renal carcinoma - evolution of metastatic disease and overall survival after four lines of targeted therapy. Case report
Author(s) -
Andreea Lăzescu,
Laura Ciurea,
Ioan Burlănescu,
D Mitulescu,
Alexandru Grigorescu
Publication year - 2017
Publication title -
oncolog-hematolog ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.41.4.2017.1349
Subject(s) - temsirolimus , medicine , sorafenib , sunitinib , renal cell carcinoma , everolimus , oncology , denosumab , nephrectomy , cancer , disease , surgery , radiology , discovery and development of mtor inhibitors , kidney , pi3k/akt/mtor pathway , hepatocellular carcinoma , apoptosis , biochemistry , chemistry , osteoporosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom